Lilly to Present at J.P. Morgan Healthcare Conference

INDIANAPOLIS, Dec. 19, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will present at the 32nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2014. John C. Lechleiter, Ph.D., Lilly's chairman, president and chief executive officer will make a formal presentation from 2:30 p.m. to 2:55 p.m. PST.

A live audio webcast will be available on the Webcasts & Presentations section of Lilly's Investor website at http://investor.lilly.com/events.cfm . Subsequently, a replay of Dr. Lechleiter's presentation will be available on this same website for approximately 90 days.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs.  Additional information about Lilly is available at www.lilly.com.  F-LLY

Refer to:    

(317) 276-5795 – Mark Taylor (Media)


(317) 655-6874 – Philip Johnson (Investors)

(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO )

SOURCE Eli Lilly and Company

Suggested Articles

Move over, Roche. There’s a new small-cell lung cancer therapy on the scene, and it belongs to AstraZeneca.

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

Gilead CEO promised to make remdesivir affordable, shortly after the company backed off its request for orphan status amid a public backlash.